避妊薬の世界市場 (2023-2030年)：製品 (経口薬・注射薬)・流通チャネル (小売薬局・病院) 別の規模・シェア・成長分析・予測

世界の避妊薬の市場規模は、2021年の280億9,000万米ドル、2022年の299億9,000万米ドルから、予測期間中は6.5%のCAGRで推移し、2030年には505億9,000万米ドルの規模に成長すると予測されています。

世界の避妊薬の市場は、いくつかの要因によって成長が見込まれています。性感染症 (STD) の増加、避妊薬や避妊器具を利用できない女性の増加などが市場成長を後押しすると予想されています。世界保健機関 (WHO) によると、世界全体で11億人を超える女性が家族計画を必要としており、約2億7,000万人の女性の避妊の需要が満たされていない状態です。無計画な妊娠を防ぎ、利用者の意識を高めるための焦点を絞ったプログラムが市場成長をさらに促進すると予測されています。

一方で、胃のむかつき、膨満感、めまい、体重増加など、避妊薬の副作用に対する懸念が市場成長を阻害する可能性があります。さらに、不妊症の蔓延や新興国市場における性教育の格差は、世界の避妊薬市場の成長を阻害する可能性があります。このような課題にもかかわらず、予測期間中は家族計画に対するニーズの高まりや意識向上・予防プログラムの実施により、避妊薬の需要は拡大するとみられています。

避妊薬は、特に貧困層や低所得層の間で、望まない妊娠の割合を低下させる上で重要な役割を果たしています。避妊薬の使用は、妊産婦死亡や安全でない人工妊娠中絶の減少に大きく貢献し、世界の人口増加や性病率の上昇に対処しています。

政府やNGOは、厳格な避妊対策を実施することで、人口増加と性病に対処する取り組みを強化しています。リプロダクティブヘルス研究所や家族計画財団など、さまざまな組織が適切な避妊に関する一般向け啓発プログラムを開始しています。

技術の進歩は避妊薬市場で勢いを増している顕著な動向であり、デジタル避妊が最新のイノベーションとなっています。デジタル避妊は、月経周期をオンラインで追跡し、妊娠リスクのある日数を決定するものです。このデジタルアプローチは、女性が不妊を管理し、望まない妊娠を避けるための新しく便利な方法を提供します。

当レポートでは、世界の避妊薬の市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。

目次

エグゼクティブサマリー

調査手法

親市場の分析

• 市場概要
• 市場規模
• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題

主要市場洞察

• 技術分析
• 価格分析
• サプライチェーン分析
• バリューチェーン分析
• 市場のエコシステム
• IP分析
• 貿易分析
• スタートアップ分析
• 原材料分析
• イノベーションマトリックス
• パイプライン製品の分析
• マクロ経済指標
• 主要投資分析
• 主要成功要因
• 競合の程度

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• 規制状況
• ポーターの分析
• 将来のディスラプションに関するSkyquestの特別な洞察

世界の避妊薬市場：製品別

• 市場概要
• 経口避妊薬
• 注射避妊薬
• 局所避妊薬

世界の避妊薬市場：流通チャネル別

• 市場概要
• 小売薬局
• 病院薬局
• クリニック
• オンライン
• 公共・NGO

世界の避妊薬市場：地域別

• 市場概要
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

競合情勢

• トップ5社の比較
• 主要企業の市場での位置付け
• 主要企業の採用戦略
• 主要成功戦略
• 市場における最近の活動
• 主要企業の市場シェア

主要企業プロファイル

• Pfizer Inc.
• Bayer AG
• Merck &Co., Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan NV
• Allergan plc
• Mithra Pharmaceuticals SA
• Afaxys, Inc.
• Reckitt Benckiser Group plc
• CooperSurgical, Inc.
• Agile Therapeutics, Inc.
• Novartis International AG
• GlaxoSmithKline plc
• Johnson &Johnson
• Merck KGaA
• HLL Lifecare Limited
• Church &Dwight Co., Inc.
• Mayer Laboratories, Inc.
• The Female Health Company
• Okamoto Industries, Inc.

Global Contraceptive Drugs Market size was valued at USD 28.09 billion in 2021 and is poised to grow from USD 29.99 billion in 2022 to USD 50.59 billion by 2030, growing at a CAGR of 6.5% in the forecast period (2023-2030)

The global contraceptive drugs market is anticipated to experience growth driven by several factors. Increasing incidences of sexually transmitted diseases (STDs) and a rising number of women with no access to contraceptive drugs and devices are expected to boost market growth. According to the World Health Organization, over 1.1 billion women of reproductive age globally require family planning, and approximately 270 million women have unmet contraceptive demand. Targeted programs to prevent unplanned pregnancies and raise user awareness are projected to further drive market growth.

However, the market also faces challenges. Concerns about the side effects of contraceptive drugs, such as stomach upset, bloating, dizziness, and weight gain, could impede market growth. Additionally, infertility prevalence and disparities in sex education in developed countries are potential obstacles to the growth of the global contraceptive drugs market. Despite these challenges, the demand for contraceptive drugs is likely to grow due to the increasing need for family planning and the implementation of awareness and prevention programs during the forecast period.

Segments covered in this report:

Global contraceptive drugs market is segmented on the basis of product, distribution channel and region. On the basis of product, global market is segmented into, oral contraceptive pills, injectable contraceptives and topical contraceptives. On the basis of distribution channel, global market is segmented into, retail pharmacy, hospital pharmacy, clinics, online channel and public channel & NGOs. On the basis of region, global market is divided into North America, Europe, Asia Pacific, Latin America, and MEA.

Driver

Preventing Unwanted Pregnancies: Contraceptive drugs play a crucial role in reducing the prevalence of unintended pregnancies, especially among poor and low-income populations who often rely on traditional methods. Their use contributes significantly to lowering maternal deaths and unsafe abortions, addressing the increasing global population and STD rates.

Government and NGO Initiatives: Governments and non-governmental organizations have intensified efforts to address population growth and STDs by implementing strict birth control measures. Various organizations, such as reproductive health institutes and family planning foundations, have launched public awareness programs on proper contraception.

Restraint

The global contraceptive drugs market faces hindrances due to the adverse effects of long-term birth control pill use. Prolonged consumption, typically over ten years, may result in side effects like headaches, bleeding, and nausea. Furthermore, medications containing oestrogen and progesterone pose an elevated risk of blood clots, potentially leading to heart attacks. These concerns about the safety of long-term use act as a restraint on the market's growth.

Market Trends

Technological advancements are a prominent trend gaining momentum in the contraceptive drugs market, with digital contraception being the latest innovation. Digital contraception involves tracking menstrual cycles online to determine days at risk for pregnancy. In March 2021, the Berlin-based femtech company Clu obtained FDA approval to market Clu Birth Control, an all-digital contraceptive relying on period monitoring data. This contraceptive function combines a user's menstrual cycle data with Clue's prediction algorithm to identify high or low-risk days for pregnancy. Users can then adjust their habits according to their risk tolerance. Clue recommends abstaining from intercourse or using additional forms of contraception, like condoms, during high-risk days. This digital approach offers a new and convenient way for women to manage their fertility and avoid unwanted pregnancies.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Contraceptive Drugs Market by Product

• Market Overview
• Oral contraceptive pills
• Injectable contraceptives
• Topical contraceptives

Global Contraceptive Drugs Market by Distribution Channel

• Market Overview
• Retail pharmacy
• Hospital pharmacy
• Clinics
• Online channel
• Public channel & NGOs

Global Contraceptive Drugs Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mithra Pharmaceuticals SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Afaxys, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis International AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HLL Lifecare Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Church & Dwight Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayer Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Female Health Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Okamoto Industries, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments